{"id":"https://openalex.org/W2149620192","doi":"https://doi.org/10.1517/13543784.10.3.417","title":"Is there a future for renin inhibitors?","display_name":"Is there a future for renin inhibitors?","publication_year":2001,"publication_date":"2001-03-01","ids":{"openalex":"https://openalex.org/W2149620192","doi":"https://doi.org/10.1517/13543784.10.3.417","mag":"2149620192","pmid":"https://pubmed.ncbi.nlm.nih.gov/11227042"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.10.3.417","doi":"https://doi.org/10.1517/13543784.10.3.417","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.10.3.417","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066125771","display_name":"Naomi D.L. Fisher","orcid":"https://orcid.org/0000-0003-1649-1441","observed_orcids":["https://orcid.org/0000-0003-1649-1441"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naomi DL Fisher","raw_affiliation_strings":["Departments of Radiology and Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston, MA, USA. nfisher@partners.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Radiology and Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston, MA, USA. nfisher@partners.org","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113527981","display_name":"Norman K. Hollenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Norman K Hollenberg","raw_affiliation_strings":["Departments of Radiology and Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, 221 Longwood Ave, Boston, MA 02115 USA. nfisher@partners.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Radiology and Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, 221 Longwood Ave, Boston, MA 02115 USA. nfisher@partners.org","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.1887,"has_fulltext":false,"cited_by_count":69,"citation_normalized_percentile":{"value":0.9250797,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"10","issue":"3","first_page":"417","last_page":"426"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/renin-inhibitors","display_name":"renin inhibitors","score":0.984000027179718},{"id":"https://openalex.org/keywords/renin-angiotensin-system","display_name":"renin-angiotensin system","score":0.996999979019165},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9190000295639038},{"id":"https://openalex.org/keywords/at1-receptor-antagonists","display_name":"AT1 receptor antagonists","score":0.9549999833106995},{"id":"https://openalex.org/keywords/angiotensinogen","display_name":"angiotensinogen","score":0.9449999928474426},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8679999709129333},{"id":"https://openalex.org/keywords/x-ray-crystallography","display_name":"X-ray crystallography","score":0.8460000157356262},{"id":"https://openalex.org/keywords/active-site-structure","display_name":"active site structure","score":0.6579999923706055},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7900000214576721},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.7300000190734863},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.847000002861023}],"concepts":[{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.8798596858978271},{"id":"https://openalex.org/C2777425892","wikidata":"https://www.wikidata.org/wiki/Q409255","display_name":"Renin inhibitor","level":4,"score":0.5571969151496887},{"id":"https://openalex.org/C188198153","wikidata":"https://www.wikidata.org/wiki/Q1613840","display_name":"Limiting","level":2,"score":0.5268158912658691},{"id":"https://openalex.org/C123915805","wikidata":"https://www.wikidata.org/wiki/Q15332826","display_name":"Angiotensin II receptor type 1","level":4,"score":0.43782490491867065},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4123561382293701},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4122586250305176},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41087448596954346},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31557098031044006},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31531211733818054},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21893492341041565},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000092502","descriptor_name":"Renin Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012083","descriptor_name":"Renin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D044139","descriptor_name":"Receptor, Angiotensin, Type 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044140","descriptor_name":"Receptor, Angiotensin, Type 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/13543784.10.3.417","doi":"https://doi.org/10.1517/13543784.10.3.417","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.10.3.417","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:11227042","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11227042","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9074000120162964,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1829832466","https://openalex.org/W1964735115","https://openalex.org/W1971914966","https://openalex.org/W1982404795","https://openalex.org/W1992702265","https://openalex.org/W1994223533","https://openalex.org/W2005582948","https://openalex.org/W2021602387","https://openalex.org/W2022526496","https://openalex.org/W2035786920","https://openalex.org/W2040803575","https://openalex.org/W2048339634","https://openalex.org/W2050359833","https://openalex.org/W2051116353","https://openalex.org/W2051652287","https://openalex.org/W2056924472","https://openalex.org/W2064654005","https://openalex.org/W2089356192","https://openalex.org/W2089657765","https://openalex.org/W2093433422","https://openalex.org/W2093561963","https://openalex.org/W2096483241","https://openalex.org/W2097638191","https://openalex.org/W2125524254","https://openalex.org/W2125943457","https://openalex.org/W2143534082","https://openalex.org/W2167192166","https://openalex.org/W2466945111"],"related_works":["https://openalex.org/W2084140014","https://openalex.org/W4235832805","https://openalex.org/W2320914922","https://openalex.org/W1990393786","https://openalex.org/W2327402356","https://openalex.org/W2044430295","https://openalex.org/W173710998","https://openalex.org/W2032908886","https://openalex.org/W2419479151","https://openalex.org/W2006794932"],"abstract_inverted_index":{"Pharmacological":[0],"interruption":[1],"of":[2,23,73,112,120,127,150,153,180,237,244,255,266],"the":[3,12,16,21,45,51,58,64,71,106,109,118,128,135,151,154,173,181,195,234,242,252,256,264],"renin-angiotensin":[4,52],"system":[5],"is":[6,44,103,171,178,185,219],"possible":[7],"at":[8,20,77],"three":[9,79],"major":[10],"sites,":[11],"angiotensin-converting":[13],"enzyme":[14],"(ACE),":[15],"AT1":[17],"receptor":[18],"and":[19,30,47,115,148,188,251,276],"interaction":[22],"renin":[24,43,59,86,113,177,201,238,267],"with":[25,249],"its":[26],"substrate,":[27],"angiotensinogen.":[28],"Skeggs":[29],"his":[31],"associates":[32],"in":[33,50,92,94,100,123,269],"1957":[34],"argued":[35],"logically":[36],"but":[37,240],"without":[38],"prognostic":[39],"accuracy":[40],"that":[41,57,75,141,184,199,214,263],"'since":[42],"initial":[46],"rate-limiting":[48],"substance":[49],"system,":[53],"it":[54,197],"would":[55,62,157],"seem":[56],"inhibition":[60,114,268],"approach":[61],"be":[63],"most":[65],"likely":[66],"to":[67,104,116,159,164,190,212,226,230],"succeed'.":[68],"In":[69],"fact,":[70],"development":[72,203],"agents":[74,122],"act":[76],"all":[78,172,200],"levels":[80],"has":[81,96,272],"enjoyed":[82],"substantial":[83,279],"success,":[84],"yet":[85],"inhibition,":[87],"which":[88],"showed":[89],"early":[90],"progress":[91],"studies":[93],"humans,":[95],"languished.":[97],"Our":[98],"task":[99],"this":[101],"essay":[102],"review":[105],"reasons":[107],"for":[108],"slow":[110],"evolution":[111],"discuss":[117],"potential":[119,236,265],"such":[121],"modern":[124],"pharmacotherapy.":[125],"All":[126],"structure-action":[129],"relationships":[130],"have":[131,165,205,231],"involved":[132],"variation":[133],"on":[134,145],"original":[136],"peptide":[137],"structure.":[138],"The":[139,224],"possibility":[140],"alternative":[142],"approaches":[143],"based":[144],"x-ray":[146,191],"crystallography":[147],"reconstruction":[149],"structure":[152],"active":[155],"site":[156],"lead":[158],"novel":[160,222],"agents,":[161],"appears":[162,198],"not":[163,233],"been":[166,206,273],"explored":[167],"systematically.":[168],"This":[169],"opportunity":[170],"more":[174],"attractive":[175],"because":[176],"one":[179,215],"few":[182],"targets":[183],"actually":[186],"soluble":[187],"amenable":[189],"crystallographic":[192],"studies.":[193],"At":[194],"moment,":[196],"inhibitor":[202],"programs":[204,228],"closed,":[207],"although":[208],"hints":[209],"periodically":[210],"reappear":[211],"indicate":[213],"company":[216],"or":[217],"another":[218],"pursuing":[220],"a":[221],"agent.":[223],"decision":[225],"close":[227],"seems":[229],"reflected":[232],"therapeutic":[235],"inhibitors,":[239],"rather":[241],"cost":[243],"their":[245],"synthesis,":[246],"continuing":[247],"problems":[248],"bioavailability":[250],"remarkable":[253],"success":[254],"competitor":[257],"class--the":[258],"AngII":[259],"antagonists.":[260],"We":[261],"believe":[262],"human":[270],"therapy":[271],"under":[274],"estimated":[275],"still":[277],"shows":[278],"promise.":[280]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}